Oskar Hansson

Professor, consultant
More filtering options
  1. 2021
  2. Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease

    Conor Owens-Walton, David Jakabek, Brian D. Power, Mark Walterfang, Sara Hall, Danielle van Westen, Jeffrey C.L. Looi, Marnie Shaw & Oskar Hansson, 2021 Jun 30, In: Psychiatry Research - Neuroimaging. 312, 111273.

    Research output: Contribution to journalArticle

  3. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

    Niklas Mattsson-Carlgren, Shorena Janelidze, Randall J. Bateman, Ruben Smith, Erik Stomrud, Geidy E. Serrano, Eric M. Reiman, Sebastian Palmqvist, Jeffrey L. Dage, Thomas G. Beach & Oskar Hansson, 2021 May 1, In: EMBO Molecular Medicine.

    Research output: Contribution to journalArticle

  4. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images

    Marco Bucci, Irina Savitcheva, Gill Farrar, Gemma Salvadó, Lyduine Collij, Vincent Doré, Juan Domingo Gispert, Roger Gunn, Bernard Hanseeuw, Oskar Hansson, Mahnaz Shekari, Renaud Lhommel, José Luis Molinuevo, Christopher Rowe, Cyrille Sur, Alex Whittington, Christopher Buckley & Agneta Nordberg, 2021 Apr 21, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  5. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19

    Lucija Klaric, Jack S Gisby, Artemis Papadaki, Marisa D Muckian, Erin Macdonald-Dunlop, Jing Hua Zhao, Alex Tokolyi, Elodie Persyn, Erola Pairo-Castineira, Andrew P Morris, Anette Kalnapenkis, Anne Richmond, Arianna Landini, Åsa K Hedman, Bram Prins, Daniela Zanetti, Eleanor Wheeler, Charles Kooperberg, Chen Yao, John R Petrie & 48 others, Jingyuan Fu, Lasse Folkersen, Mark Walker, Martin Magnusson, Niclas Eriksson, Niklas Mattsson-Carlgren, Paul R H J Timmers, Shih-Jen Hwang, Stefan Enroth, Stefan Gustafsson, Urmo Vosa, Yan Chen, Agneta Siegbahn, Alexander Reiner, Åsa Johansson, Barbara Thorand, Bruna Gigante, Caroline Hayward, Christian Herder, Christian Gieger, Claudia Langenberg, Daniel Levy, Daria V Zhernakova, J Gustav Smith, Harry Campbell, Johan Sundstrom, John Danesh, Karl Michaëlsson, Karsten Suhre, Lars Lind, Lars Wallentin, Leonid Padyukov, Mikael Landén, Nicholas J Wareham, Andreas Göteson, Oskar Hansson, Rona J Strawbridge, Themistocles L Assimes, Tonu Esko, Ulf Gyllensten, J Kenneth Baillie, Dirk S Paul, Peter K Joshi, Adam S Butterworth, Anders Mälarstig, Nicola Pirastu, James F Wilson & James E Peters, 2021 Apr 7

    Research output: Other contributionMiscellaneous

  6. Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

    E. E. Wolters, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, O. Hansson, A. Nordberg, G. B. Frisoni, V. Garibotto & R. Ossenkoppele, 2021 Feb 6, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  7. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts

    Karine Provost, Leonardo Iaccarino, David N. Soleimani-Meigooni, Suzanne Baker, Lauren Edwards, Udo Eichenlaub, Oskar Hansson, William Jagust, Mustafa Janabi, Renaud La Joie, Orit Lesman-Segev, Taylor J. Mellinger, Bruce L. Miller, Rik Ossenkoppele, Julie Pham, Ruben Smith, Ida Sonni, Amelia Strom, Niklas Mattsson-Carlgren, Gil D. Rabinovici & 1 others, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2021 Jan 4, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  8. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

    A. Leuzy, N. J. Ashton, N. Mattsson-Carlgren, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, A. Nordberg, R. Ossenkoppele, H. Zetterberg, K. Blennow, G. B. Frisoni, V. Garibotto & O. Hansson, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  9. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age

    Scott Ayton, Shorena Janelidze, Blaine Roberts, Sebastian Palmqvist, Pawel Kalinowski, Ibrahima Diouf, Abdel A. Belaidi, Erik Stomrud, Ashley I. Bush & Oskar Hansson, 2021, In: Progress in Neurobiology. 198, 101904.

    Research output: Contribution to journalArticle

  10. Biomarker testing in MCI patients—deciding who to test

    Ingrid S. van Maurik, Hanneke F.M. Rhodius-Meester, Charlotte E. Teunissen, Philip Scheltens, Frederik Barkhof, Sebastian Palmqvist, Oskar Hansson, Wiesje M. van der Flier & Johannes Berkhof, 2021, In: Alzheimer's Research and Therapy. 13, 1, 14.

    Research output: Contribution to journalArticle

  11. Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

    Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte E. Teunissen & Kaj Blennow, 2021, In: Alzheimer's Research and Therapy. 13, 1, 38.

    Research output: Contribution to journalArticle

  12. Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease

    Ellen Singleton, Oskar Hansson, Yolande A.L. Pijnenburg, Renaud La Joie, William G. Mantyh, Pontus Tideman, Erik Stomrud, Antoine Leuzy, Maurits Johansson, Olof Strandberg, Ruben Smith, Evi Berendrecht, Bruce L. Miller, Leonardo Iaccarino, Lauren Edwards, Amelia Strom, Emma E. Wolters, Emma Coomans, Denise Visser, Sandeep S.V. Golla & 9 others, Hayel Tuncel, Femke Bouwman, John Cornelis Van Swieten, Janne M. Papma, Bart Van Berckel, Philip Scheltens, Anke A. Dijkstra, Gil D. Rabinovici & Rik Ossenkoppele, 2021, (Accepted/In press) In: Journal of Neurology, Neurosurgery and Psychiatry.

    Research output: Contribution to journalArticle

  13. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

    Elena Camporesi, Tammaryn Lashley, Johan Gobom, Juan Lantero-Rodriguez, Oskar Hansson, Henrik Zetterberg, Kaj Blennow & Bruno Becker, 2021, In: Acta Neuropathologica Communications. 9, 1, 19.

    Research output: Contribution to journalArticle

  14. Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease

    Oskar Hansson, Nicholas Cullen, Henrik Zetterberg, Kaj Blennow, Niklas Mattsson-Carlgren & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2021, In: Annals of Clinical and Translational Neurology. 8, 1, p. 259-265

    Research output: Contribution to journalArticle

  15. The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

    Oskar Hansson, Richard Batrla, Britta Brix, Maria C. Carrillo, Veronika Corradini, Rebecca M. Edelmayer, Rianne N. Esquivel, Christina Hall, John Lawson, Nathalie Le Bastard, José Luis Molinuevo, Laura K. Nisenbaum, Sandra Rutz, Salvatore J. Salamone, Charlotte E. Teunissen, Christopher Traynham, Robert M. Umek, Hugo Vanderstichele, Manu Vandijck, Simone Wahl & 3 others, Christopher J. Weber, Henrik Zetterberg & Kaj Blennow, 2021, In: Alzheimer's and Dementia.

    Research output: Contribution to journalArticle

  16. The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

    Marina Boccardi, Alessandra Dodich, Emiliano Albanese, Angèle Gayet-Ageron, Cristina Festari, Nicholas J. Ashton, Gérard N. Bischof, Konstantinos Chiotis, Antoine Leuzy, Emma E. Wolters, Martin A. Walter, Gil D. Rabinovici, Maria Carrillo, Alexander Drzezga, Oskar Hansson, Agneta Nordberg, Rik Ossenkoppele, Victor L. Villemagne, Bengt Winblad, Giovanni B. Frisoni & 1 others, Valentina Garibotto, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  17. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

    N. J. Ashton, A. Leuzy, T. K. Karikari, N. Mattsson-Carlgren, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, A. Nordberg, R. Ossenkoppele, H. Zetterberg, K. Blennow, G. B. Frisoni, V. Garibotto & O. Hansson, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  18. Time between milestone events in the Alzheimer's disease amyloid cascade

    Philip S. Insel, Michael C. Donohue, David Berron, Oskar Hansson & Niklas Mattsson-Carlgren, 2021, In: NeuroImage. 227, 117676.

    Research output: Contribution to journalArticle

  19. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease

    Joana B. Pereira, Shorena Janelidze, Rik Ossenkoppele, Hlin Kvartsberg, Ann Brinkmalm, Niklas Mattsson-Carlgren, Erik Stomrud, Ruben Smith, Henrik Zetterberg, Kaj Blennow & Oskar Hansson, 2021, In: Brain : a journal of neurology. 144, 1, p. 310-324 15 p.

    Research output: Contribution to journalArticle

  20. 2020
  21. Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies

    Sara Linse, Tom Scheidt, Katja Bernfur, Michele Vendruscolo, Christopher M. Dobson, Samuel I.A. Cohen, Eimantas Sileikis, Martin Lundqvist, Fang Qian, Tiernan O’Malley, Thierry Bussiere, Paul H. Weinreb, Catherine K. Xu, Georg Meisl, Sean R.A. Devenish, Tuomas P.J. Knowles & Oskar Hansson, 2020 Dec, In: Nature Structural and Molecular Biology. 27, 12, p. 1125-1133 9 p.

    Research output: Contribution to journalArticle

  22. The impact of demographic, clinical, genetic, and imaging variables on tau PET status

    Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, Carole H. Sudre, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Tomas Olsson, Jonas Jögi, Erik Stormrud, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria L. Gorno-Tempini, Bruce L. Miller, David Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, Edilio Borroni & 7 others, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, Sylvia Villeneuve, Chul Hyoung Lyoo, Gil D. Rabinovici & Oskar Hansson, 2020 Nov 19, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  23. Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease

    David Mengel, Shorena Janelidze, Robert J. Glynn, Wen Liu, Oskar Hansson & Dominic M. Walsh, 2020 Nov 1, In: Annals of Neurology. 88, 5, p. 878-892 15 p.

    Research output: Contribution to journalArticle

  24. Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

    Nicholas C. Cullen, Henrik Zetterberg, Philip S. Insel, Bob Olsson, Ulf Andreasson, Kaj Blennow, Oskar Hansson & Niklas Mattsson-Carlgren, 2020 Sep, In: Annals of Clinical and Translational Neurology. 7, 9, p. 1661-1673 13 p.

    Research output: Contribution to journalArticle

  25. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

    Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E. Serrano, Antoine Leuzy, Niklas Mattsson-Carlgren, Olof Strandberg, Ruben Smith, Andres Villegas, Diego Sepulveda-Falla, Xiyun Chai, Nicholas K. Proctor, Thomas G. Beach, Kaj Blennow, Jeffrey L. Dage & 2 others, Eric M. Reiman & Oskar Hansson, 2020 Aug 25, In: JAMA - Journal of the American Medical Association. 324, 8, p. 772-781 10 p.

    Research output: Contribution to journalArticle

  26. Alcohol Consumption and Risk of Parkinson's Disease: Data from a Large Prospective European Cohort

    Susan Peters, Valentina Gallo, Paolo Vineis, Lefkos T. Middleton, Lars Forsgren, Carlotta Sacerdote, Sabina Sieri, Andreas Kyrozis, María Dolores Chirlaque, Raul Zamora-Ros, Oskar Hansson, Jesper Petersson, Verena Katzke, Tilman Kühn, Olatz Mokoroa, Giovanna Masala, Eva Ardanaz, Salvatore Panico, Manuela M. Bergmann, Timothy J. Key & 3 others, Elisabete Weiderpass, Pietro Ferrari & Roel Vermeulen, 2020 Jul, In: Movement Disorders. 35, 7, p. 1258-1263 6 p.

    Research output: Contribution to journalArticle

  27. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

    Joana B. Pereira, Sara Hall, Mattis Jalakas, Michel J. Grothe, Olof Strandberg, Erik Stomrud, Eric Westman, Danielle van Westen & Oskar Hansson, 2020 Jun, In: Neurobiology of Disease. 139, 104831.

    Research output: Contribution to journalArticle

  28. Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

    Jacob W. Vogel, Yasser Iturria-Medina, Olof T. Strandberg, Ruben Smith, Elizabeth Levitis, Alan C. Evans, Oskar Hansson, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, Swedish BioFinder Study Swedish BioFinder Study, Jimmy Lätt, Markus Nilsson, Freddy Ståhlberg, Pia Maly Sundgren, Danielle van Westen, Jonas Jögi, Douglas Hägerström, Tomas G Olsson & Per Wollmer, 2020 May 26, In: Nature Communications. 11, 2612.

    Research output: Contribution to journalArticle

  29. Assessment of Demographic, Genetic, and Imaging Variables Associated with Brain Resilience and Cognitive Resilience to Pathological Tau in Patients with Alzheimer Disease

    Rik Ossenkoppele, Chul Hyoung Lyoo, Jonas Jester-Broms, Carole H. Sudre, Hanna Cho, Young Hoon Ryu, Jae Yong Choi, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Joel Kramer, Adam L. Boxer, Maria L. Gorno-Tempini, Bruce L. Miller, Renaud La Joie, Gil D. Rabinovici & Oskar Hansson, 2020 May, In: JAMA Neurology. 77, 5, p. 632-642 11 p.

    Research output: Contribution to journalArticle

  30. The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults

    Philip S. Insel, Michael C. Donohue, Reisa Sperling, Oskar Hansson & Niklas Mattsson-Carlgren, 2020 May, In: Annals of Clinical and Translational Neurology. 7, 5, p. 776-785 10 p.

    Research output: Contribution to journalArticle

  31. Alzheimers sjukdom – diagnostik och behandling i dag och i framtiden

    Nenad Bogdanovic, Oskar Hansson, Henrik Zetterberg, Hans Basun, Martin Ingelsson, Lars Lannfelt & Kaj Blennow, 2020 Mar 9, In: Läkartidningen. 117, FZHM.

    Research output: Contribution to journalArticle

  32. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

    Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G. Beach, Geidy E. Serrano, Xiyun Chai, Nicholas K. Proctor, Udo Eichenlaub, Henrik Zetterberg, Kaj Blennow, Eric M. Reiman, Erik Stomrud, Jeffrey L. Dage & Oskar Hansson, 2020 Mar 2, In: Nature Medicine. 26, 3, p. 379-386 8 p.

    Research output: Contribution to journalArticle

  33. Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders

    Sara Hall, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Niklas Mattsson, Yulia Surova, Kaj Blennow & Oskar Hansson, 2020 Mar, In: Movement Disorders. 35, 3, p. 513-518 6 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 Next